19,410 Shares in Danaher Corporation $DHR Purchased by Edgestream Partners L.P.

Edgestream Partners L.P. purchased a new stake in shares of Danaher Corporation (NYSE:DHR) in the 1st quarter, Holdings Channel reports. The fund purchased 19,410 shares of the conglomerate’s stock, valued at approximately $3,680,000.

Other hedge funds have also recently bought and sold shares of the company. Main Street Group LTD acquired a new position in shares of Danaher during the 1st quarter worth approximately $25,000. JPL Wealth Management LLC acquired a new stake in shares of Danaher in the 3rd quarter valued at approximately $25,000. Elevated Capital Advisors LLC bought a new position in shares of Danaher in the fourth quarter valued at $26,000. WFA of San Diego LLC bought a new position in shares of Danaher in the second quarter valued at $26,000. Finally, Hilton Head Capital Partners LLC acquired a new position in Danaher during the fourth quarter worth $27,000. 79.05% of the stock is currently owned by institutional investors.

Wall Street Analyst Weigh In

Several analysts have issued reports on the stock. UBS Group dropped their price target on shares of Danaher from $270.00 to $250.00 and set a “buy” rating on the stock in a research report on Wednesday, April 22nd. Piper Sandler assumed coverage on shares of Danaher in a research report on Thursday, June 11th. They issued a “neutral” rating and a $200.00 price objective for the company. TD Cowen lowered their price objective on shares of Danaher from $240.00 to $236.00 and set a “buy” rating on the stock in a research note on Wednesday, July 22nd. DZ Bank began coverage on shares of Danaher in a report on Wednesday, June 3rd. They issued a “buy” rating and a $210.00 target price on the stock. Finally, Guggenheim cut their target price on shares of Danaher from $235.00 to $200.00 and set a “buy” rating for the company in a research note on Wednesday, July 22nd. One analyst has rated the stock with a Strong Buy rating, nineteen have issued a Buy rating and five have issued a Hold rating to the stock. Based on data from MarketBeat, the company has a consensus rating of “Moderate Buy” and an average price target of $228.91.

Danaher Stock Down 0.5%

DHR opened at $195.25 on Friday. The stock’s fifty day simple moving average is $188.36 and its 200 day simple moving average is $195.66. Danaher Corporation has a 1-year low of $160.93 and a 1-year high of $242.80. The stock has a market cap of $137.26 billion, a PE ratio of 34.68, a price-to-earnings-growth ratio of 2.43 and a beta of 0.79. The company has a current ratio of 1.65, a quick ratio of 1.25 and a debt-to-equity ratio of 0.48.

Danaher (NYSE:DHR) last released its quarterly earnings data on Tuesday, July 21st. The conglomerate reported $1.94 EPS for the quarter, topping analysts’ consensus estimates of $1.85 by $0.09. Danaher had a net margin of 15.95% and a return on equity of 11.04%. The firm had revenue of $6.26 billion during the quarter, compared to analysts’ expectations of $6.12 billion. During the same period in the previous year, the business posted $0.77 earnings per share. The company’s revenue for the quarter was up 5.5% compared to the same quarter last year. As a group, research analysts expect that Danaher Corporation will post 8.53 earnings per share for the current year.

Danaher Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Friday, July 31st. Stockholders of record on Friday, June 26th were paid a dividend of $0.40 per share. This represents a $1.60 dividend on an annualized basis and a dividend yield of 0.8%. The ex-dividend date was Friday, June 26th. Danaher’s dividend payout ratio (DPR) is currently 28.42%.

Danaher Company Profile

Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.